Tag: obesity
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Aging Activates Belly Fat Stem Cells: New Clues to Middle-Age Weight Gain
Aging activates specialized stem cells in abdominal tissue that accelerate belly fat production, according to preclinical research. The discovery identifies…
Why Food Labels Alone Won’t Stop Child Obesity in Latin America—Evidence From Ecuador
Latin American countries have implemented front-of-package warning labels and advertising restrictions, yet childhood obesity continues to rise. Evidence from Ecuador…
Weekly Dual-Hormone Injection Reduces Liver Fat by 67% in Obesity Trial
Phase 3 trial shows weekly survodutide injections reduced liver fat by 67% and achieved 18.5% weight loss in adults with…
American Horses Mirror Human Obesity Crisis, Revealing Shared Environmental Risk Factors
American horses are developing obesity and metabolic syndrome at unprecedented rates, mirroring human health trends. This cross-species crisis reveals shared…
Survodutide Weekly Injection Shows 17.5% Weight Loss in Phase 3 Obesity Trial
Phase 3 trial shows survodutide weekly injection achieved 17.5% weight loss versus 1.2% placebo in over 3,400 adults with obesity.…
Oral GLP-1 Drug Achieves 11.3% Weight Loss in Phase 2 Trial
Phase 2b trial shows oral GLP-1 drug aleniglipron achieved 11.3% weight loss in 230 adults with obesity. Results suggest oral…
Tomato-Soy Juice Blend Reduces Obesity-Related Inflammation in Clinical Trial
A clinical trial shows that a specially formulated tomato-soy juice reduced obesity-related inflammatory markers by up to 23% in just…